Cortex Pharmaceuticals Inc.: The Irvine-based company said...
- Share via
Cortex Pharmaceuticals Inc.: The Irvine-based company said Friday that its shareholders approved a 1-for-5 reverse stock split at the company’s annual meeting Thursday. The split will become effective Jan. 11. “We hope a higher per share price will attract more institutional investors,” said Scott Hagen, Cortex’s chief financial officer.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
